Congenital heart defect

The Children's Heart Foundation Launches Inaugural Underrepresented Minority in Medicine Research Training Award

Retrieved on: 
Wednesday, April 3, 2024
Alaska Natives, African Americans, Letter, Cardiology, Research, Children, Native Hawaiians, Homeland security, Congenital heart defect, Health, Medicine

The URMRTA reflects The Children's Heart Foundation's commitment to diversity, equity, and inclusion in healthcare and medical research, specifically pediatric cardiology research related to CHDs.

Key Points: 
  • The URMRTA reflects The Children's Heart Foundation's commitment to diversity, equity, and inclusion in healthcare and medical research, specifically pediatric cardiology research related to CHDs.
  • "We're excited to launch this training award as part of our ongoing efforts to promote diversity and excellence in medicine in the area of congenital heart defect research," said Gail Roddie-Hamlin, President & CEO at The Children's Heart Foundation.
  • "Through this grant, we aim to provide support to underrepresented minority individuals pursuing careers in medical research, empowering them to make significant contributions to healthcare innovation and patient care."
  • The Children's Heart Foundation invites eligible individuals to apply for the Underrepresented Minority in Medicine Research Training Award.

Global Pediatric Interventional Cardiology Market Forecast 2024-2030: PIC Market Forecast for 6.36% CAGR Between 2024 to 2030 - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 29, 2024
General Health, Health, Cardiology, Heart, Incidence, Procedure, Catheter, Birth defect, Investment, Physician, Moyamoya disease, Congenital heart defect, Projection, VSD, Angioplasty, Prevalence, CHD, Coronary thrombosis, Atherectomy, Patient, Stent, Ventricular septal defect, CDC, Catheter ablation, Research, Medical imaging

The Pediatric Interventional Cardiology Market is forecasted to reach US$ 3.91 Billion through 2030.

Key Points: 
  • The Pediatric Interventional Cardiology Market is forecasted to reach US$ 3.91 Billion through 2030.
  • The pediatric interventional cardiology market proportion is expanding swiftly, driven by the rising prevalence of cardiac disorders in children and technological advancements.
  • The Stents segment is anticipated to dominate the global pediatric interventional cardiology market throughout the forecast period.
  • The comprehensive infrastructure of hospitals, coupled with their ability to provide diverse pediatric cardiology services, positions them as key contributors to the growth and development of the Pediatric Interventional Cardiology market.

BandHealth Emerges as the New Face of SelfiHealth, Embarking on a Transformative Journey to Amplify Meaningful Health Connections

Retrieved on: 
Thursday, February 22, 2024
Human services, Social isolation, Pfizer, Algorithm, Broward Health, Social connection, Smoking, Congenital heart defect, Loneliness, Life, Huntington Hospital, Health, Private sector, Death, Patient, Integration, Bhargava, Pharmaceutical industry

NEW YORK, Feb. 22, 2024 /PRNewswire-PRWeb/ -- BandHealth, an innovative mobile app that is reshaping the peer health support landscape in the digital age, is dedicated to leveraging technology to provide meaningful connections for individuals grappling with health concerns. Today, the company is thrilled to unveil its strategic rebrand from SelfiHealth to BandHealth, aligning seamlessly with its progressive initiatives.

Key Points: 
  • Founder Zach Gotlib, a heart surgery survivor, aims to revolutionize patient-caregiver connections and shift the focus from individual to collective health.
  • BandHealth, beyond its focus on health conditions, aspires to revolutionize patient-caregiver connections, marking just the beginning of transformative change in this space.
  • Revolutionizing health support, BandHealth employs advanced algorithms to match individuals with similar health challenges, connecting them with trained health mentors who understand both their health concerns and personal backgrounds to deliver profound results.
  • BandHealth, beyond its focus on health conditions, aspires to revolutionize patient-caregiver connections, marking just the beginning of transformative change in this space.

Appendix 4C Quarterly Activity Report for Quarter Ended December 31, 2023

Retrieved on: 
Wednesday, January 31, 2024
Congenital heart defect, FDA, Appendix, MSB, Journal, Bangladesh Technical Education Board, PRV, Survival, Randomized controlled trial, Biopharmaceutical, GVHD, Phases of clinical research, BLA, Hypoplastic left heart syndrome, RPD, HLHS, Growth, Patient, Blood, Inflammation, Priority review, Heart, NIH, Pain, Mesoblast, Ageing, BMT, Executive, MESO, Pharmaceutical industry

NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an activity report for the second quarter ended December 31, 2023.

Key Points: 
  • NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an activity report for the second quarter ended December 31, 2023.
  • Mesoblast will provide the Phase 3 trial protocol to FDA ahead of the upcoming meeting this quarter.
  • Mesoblast will meet with FDA this quarter to address potential pathways to approval for REVASCOR under our Regenerative Medicine Advanced Therapies (RMAT) designation.
  • Revenue from royalties on sales of TEMCELL® HS Inj.5 sold in Japan by our licensee for the quarter were US$1.5 million.

Alberta Children's Hospital Foundation chosen as charity partner of 2024 CPKC Women's Open

Retrieved on: 
Thursday, February 1, 2024
Partnership, Parent, Hospital, Golf Canada, Congenital heart defect, Ventricular septal defect, CPKC, Caregiver, AB, Country club, Tournament, LPGA, Anomaly, Prenatal care, Alberta Children's Hospital, Women's Open, Gold

CALGARY, AB, Feb. 1, 2024 /PRNewswire/ - Canadian Pacific Kansas City (CPKC) is proud to announce that Alberta Children's Hospital Foundation has been chosen as the primary charity partner for the 2024 CPKC Women's Open, to be held at the historic Earl Grey Golf Club from July 23 – 28, 2024.

Key Points: 
  • CALGARY, AB, Feb. 1, 2024 /PRNewswire/ - Canadian Pacific Kansas City (CPKC) is proud to announce that Alberta Children's Hospital Foundation has been chosen as the primary charity partner for the 2024 CPKC Women's Open, to be held at the historic Earl Grey Golf Club from July 23 – 28, 2024.
  • "CPKC is pleased to once again partner with the Alberta Children's Hospital through the 2024 CPKC Women's Open," said Keith Creel, CPKC President and CEO.
  • "By building on our first Women's Open partnership with Alberta Children's Hospital in 2016, we will leverage our community investment program, CPKC Has Heart, to help the youngest hearts across Alberta."
  • I know that golf fans and event enthusiasts will celebrate the CPKC Women's Open as a week-long festival experience that will leave a meaningful community legacy in support of the Alberta Children's Hospital Foundation."

Good Time Brewing Company Expands with Direct-to-Consumer Shipping in Time for Dry January

Retrieved on: 
Thursday, January 4, 2024
Shannon McFerran, Congenital heart defect, Athlete, Nielsen, IPA, Citrus, Spaniards, Beer, Drinking

NEW YORK, Jan. 4, 2024 /PRNewswire/ -- Good Time Brewing Company, founded by bar industry luminary Michael "Mikey" McFerran, proudly announces the launch of direct-to-consumer sales for its non-alcoholic beer. The brand successfully debuted in New York City in Fall 2023 with a curated list of establishments such as Veselka and Attaboy, and is now available for at-home enjoyment. Nationwide shipping through goodtimebrewing.com is accessible just in time for Dry January.

Key Points: 
  • Nationwide shipping through goodtimebrewing.com is accessible just in time for Dry January.
  • Mikey McFerran, creator of Good Time Brewing and founder of NYC's The Spaniard, was inspired to enter the fast-emerging non-alcoholic brewing market following the birth of his son with a congenital heart defect in 2020.
  • With direct-to-consumer shipping, Good Time Brewing ensures beer enthusiasts nationwide have access to their non-alcoholic brew.
  • This 'hybrid' style aims to entice beer enthusiasts and pave the way for more experimentation in the realm of non-alcoholic beer.

Good Time Brewing Company Expands With Direct-to-Consumer Shipping in Time for Dry January –Storied West Village Bar Owner Embraces N/A Wave–

Retrieved on: 
Wednesday, January 3, 2024
Online Retail, Retail, Wine & Spirits, Athlete, Drinking, Shannon McFerran, IPA, Beer, Congenital heart defect, Nielsen, Citrus, Spaniards

Good Time Brewing Company, founded by bar industry luminary Michael “Mikey” McFerran, proudly announces the launch of direct-to-consumer sales for its non-alcoholic beer.

Key Points: 
  • Good Time Brewing Company, founded by bar industry luminary Michael “Mikey” McFerran, proudly announces the launch of direct-to-consumer sales for its non-alcoholic beer.
  • Nationwide shipping through goodtimebrewing.com is accessible just in time for Dry January.
  • With direct-to-consumer shipping, Good Time Brewing ensures beer enthusiasts nationwide have access to their non-alcoholic brew.
  • This ‘hybrid’ style aims to entice beer enthusiasts and pave the way for more experimentation in the realm of non-alcoholic beer.

Accarent Health Offers Industry Leading Pediatric Network of Excellence

Retrieved on: 
Monday, October 23, 2023
We, CAR, Children's Hospital Los Angeles, Adolescence, Health, Patient, Fever, News, Congenital heart defect, Hospital, Craniotomy, U.S. News & World Report, Cancer, U.S. News & World Report Best Hospitals Rankings, Patient safety, Honors student, Nursing, MD

Pediatric specialists are often a better choice when treating severe or rare afflictions that could be severely detrimental or even fatal, to young children.

Key Points: 
  • Pediatric specialists are often a better choice when treating severe or rare afflictions that could be severely detrimental or even fatal, to young children.
  • In 2023, only 89 children’s hospitals were ranked in at least one of the 10 pediatric specialties evaluated.
  • As the premier pediatric network, Accarent Health is able to provide access to the best children’s hospitals nationwide, often to members who may not have had access otherwise.
  • Every hospital in the growing Accarent pediatric network was included in the U.S. News & World Report Best Children’s Hospitals Rankings.

UltraNav System Enables Safer and More Cost-Effective Transseptal Procedures by Aligning Catheter and Ultrasound

Retrieved on: 
Wednesday, October 11, 2023
Hospital, Congenital heart defect, Physician, PFO, ICE, PST, Cardiology, Heart, Safety, TEE, Learning curve, Catheter, RF, FDA, Orientation, ASD, Anesthesia, Needle, DIB, TCT, Patient, Medical device, Medical imaging

SCOTTSDALE, Ariz., Oct. 11, 2023 /PRNewswire/ -- Franklin Mountain Medical announced today that the Dib UltraNav Transseptal Catheter System, which houses a needle and ultrasound in one system for use in atrial transseptal procedures and delivery of catheters, has now been successfully used in 15 human cases, at major cardiology hospitals in Arizona and Minnesota.

Key Points: 
  • The significant rise in structural transseptal heart procedures mandates the need for a safer, more accurate approach.
  • UltraNav improves the safety and accuracy of transseptal procedures by enabling better visualization of the catheter, needle, and needle tip.
  • "There's been a significant rise in structural transseptal heart procedures, which mandates the need for a safer, more accurate approach," said Dr. Nabil Dib, founder of Dib UltraNav Medical and inventor of the UltraNav Transseptal Catheter System.
  • The single-use, dual-lumen, non-steerable Dib UltraNav System intravascular catheter and handle received FDA 510(k) clearance in March 2022.

Accelecom Proudly Supports Finn Fest: A Celebration of Courage, Creativity, and Community

Retrieved on: 
Tuesday, August 22, 2023
Music, Partnership, Life, Face, Ventricular septal defect, Congenital heart defect, Burl, Hope, Research, Creativity, Love, CHD, Burl Ives and the Korean Orphan Choir Sing of Faith and Joy, Roller Derby of Central Kentucky, Entertainment, Furniture

Born with several congenital heart defects, Finn faced a challenging journey from the very beginning.

Key Points: 
  • Born with several congenital heart defects, Finn faced a challenging journey from the very beginning.
  • "Accelecom is deeply honored to be part of Finn Fest, a celebration that not only commemorates Finn's remarkable journey but also raises funds for Congenital Heart Defect (CHD) research and awareness.
  • His willingness to share his story and proudly display his "zipper" scar from surgeries touched hearts and ignited hope.
  • "The Collier Crew, Finn's family, is deeply moved by Accelecom's support for Finn Fest," shared John Collier, Finn's father.